Platelet Rich Plasma in Gynecology

Aesthetic Medicine: PRP (Platelet-Rich Plasma)
Aesthetic Medicine: PRP (Platelet-Rich Plasma)

For some years now we have been hearing about the use of Platelet Rich Plasma (PRP) in various fields, mainly in plastic surgery, traumatology and dental implant surgery.

PRP: Platelet Rich Plasma PRP: Platelet Rich Plasma

Platelet Rich Plasma (PRP) is a platelet concentrate obtained by centrifuging the patient’s own blood. The resulting fraction has a platelet concentration four times higher than the normal concentration of blood in the body.

Platelet Rich Plasma in Gynecology

With the injection of this fraction of platelet-rich plasma we seek to reverse the signs of aging of the mucous membranes and skin by the action of these growth factors released. The fibroblasts responsible for the synthesis of collagen, elastin and hyaluronic acid, indispensable components to maintain the structure of the tissues, will be activated. Its action also stimulates angiogenesis (formation of new blood vessels) and mitogenesis (formation of new cells). All these changes improve dryness, atrophy, flaccidity, dyschromias (color alterations) and improve the texture, tone, color, brightness and luminosity of the skin and mucous membranes.

In which women is PRP indicated?

  • Post menopausal women with vaginal dryness and contraindication for hormonal treatments (breast cancer, severe varicose veins, history of thrombosis or trobophlebitis, hepatic insufficiency, etc.).
  • Women who will undergo vaginal surgery procedures.
  • Women undergoing postoperative vaginal surgery.
  • Vaginal atrophy after oncological or systemic treatments.
  • Dry vagina syndrome in women of childbearing age.
  • Vaginal dryness in lactation.

In which women is PRP contraindicated?

  • It cannot be applied without a previous gynecological evaluation that rules out infections in the genitourinary tract, cervical disease, i.e. the patient must have a normal Pap smear or Papanicolau, with a validity equal to or less than one year.
  • It should not be placed in patients undergoing treatment with anticoagulants and/or aspirin, chemotherapy or local implants to provide radiotherapy for neck cancer.
  • Another contraindication is when there is a known diagnosis of blood dyscrasias, thrombocytopenic purpura, and other chronic hematological disorders.
Share this :
Subscribe to our newsletter to receive updates, news, analysis or promotions.